Oncology nurse pride How Have Your Family Experiences With Cancer Impacted Your Decision to Become an Oncology Nurse? June 09, 2017
Genetics & genomics The Story of Henrietta Lacks Sheds Light on Ethical Considerations in Genetic Testing April 28, 2017
Topic Adjuvant therapy Adjuvant therapy Gene Expression Helps Predict Benefit From Adjuvant Chemo for Breast Cancer Although nearly 60% of all patients with early-stage breast cancer are given adjuvant chemotherapy, only 2%–15% of them receive clinical benefit, according to research published in the 2016 American Society of Clinical Oncology Educational Book. October 18, 2016 Adjuvant therapy Outpatient Oncology Drug Series: Oxaliplatin Hates the Cold Oxaliplatin is a cytotoxic (toxic to normal cells) chemotherapy drug that is classified as an alkylating agent as well as a platinum analogue. It is indicated for a number of different cancers including colorectal, esophageal, gastric, hepatobiliary, Non-Hodgkin lymphoma, ovarian, pancreatic, and testicular cancer. January 16, 2015 Trending Topics Safety Research Standards Treatments ONS Congress Clinical Practice Immunotherapy U.S. Food and Drug Administration (FDA) Cancer research Nursing education View All Topics
Adjuvant therapy Gene Expression Helps Predict Benefit From Adjuvant Chemo for Breast Cancer Although nearly 60% of all patients with early-stage breast cancer are given adjuvant chemotherapy, only 2%–15% of them receive clinical benefit, according to research published in the 2016 American Society of Clinical Oncology Educational Book. October 18, 2016
Adjuvant therapy Outpatient Oncology Drug Series: Oxaliplatin Hates the Cold Oxaliplatin is a cytotoxic (toxic to normal cells) chemotherapy drug that is classified as an alkylating agent as well as a platinum analogue. It is indicated for a number of different cancers including colorectal, esophageal, gastric, hepatobiliary, Non-Hodgkin lymphoma, ovarian, pancreatic, and testicular cancer. January 16, 2015
